Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-audited Financial Results ....
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has informed the stock exchanges that its Board of Directors will meet on Tuesday, August 12, 2025. The main items on the agenda are to consider and approve the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). The Board will also consider the declaration of an interim dividend, if any, for the financial year 2025-26. The trading window for employees and connected persons has been closed from August 5 to August 14, 2025, in line with insider trading regulations. This is a standard advance intimation under SEBI listing rules and contains no actual financial figures.
Routine compliance filing with no direct near-term impact on shareholders. Investors should watch the August 12 outcome for actual Q1 earnings and any dividend announcement, which could influence the stock price.